RBC Capital analyst Shagun Singh lowered the firm’s price target on Zimmer Biomet (ZBH) to $125 from $130 but keeps an Outperform rating on the ...
Zimmer Biomet posted fourth-quarter revenue growth of 5% in constant currency, which is generally consistent with the preceding quarters in 2024. Why it matters: As Zimmer Biomet has pursued a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results